Edesa Biotech, Inc. (EDSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 14.02M |
| Enterprise Value | 3.23M |
| P/E Ratio | -2.62 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.53 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.26 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.11 |
| Return On Equity | -1.24 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -119,273 |
| EBITDA | -7.07M |
| Net Income | -7.19M |
| Diluted EPS | -1.27 |
| Total Cash | 10.33M |
| Total Cash/Share | 1.15 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.76 |
| Book Value Per Share | 0.98 |
| 52-Week Change | 83.06 |
| 52-Week High | 20.32 |
| 52-Week Low | 0.72 |
| Moving Average 50 Days | 6.21 |
| Moving Average 200 Days | 5.13 |
| Average Volume | 140,411 |
| Shares Outstanding | 9.63M |
| % Held by Institutions | 32.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | October 11, 2023 |